TY - JOUR
T1 - Chondromyxoid fibroma of the jaws
T2 - Case report and review of the literature
AU - Hammad, Huda M.
AU - Hammond, Harold L.
AU - Kurago, Zoya B.
AU - Frank, John A.
PY - 1998
Y1 - 1998
N2 - Chondromyxoid fibroma is a benign tumor of bone that is characterized by chondroid and myxoid differentiation and by ultrastructural and immunohistochemical evidence of chondral origin. It is rare in the jaws and skull bones, where only about 2% of all cases have been reported. A review of the 20 acceptable gnathic cases in the literature and of the current case revealed both a higher incidence in the mandible (76%) than in the maxilla (24%) and an equal sex distribution. The sites of occurrence in both jaws are compatible with origin from developmental cartilaginous remnants. The controversies regarding malignant transformation and therapeutic approach are addressed.
AB - Chondromyxoid fibroma is a benign tumor of bone that is characterized by chondroid and myxoid differentiation and by ultrastructural and immunohistochemical evidence of chondral origin. It is rare in the jaws and skull bones, where only about 2% of all cases have been reported. A review of the 20 acceptable gnathic cases in the literature and of the current case revealed both a higher incidence in the mandible (76%) than in the maxilla (24%) and an equal sex distribution. The sites of occurrence in both jaws are compatible with origin from developmental cartilaginous remnants. The controversies regarding malignant transformation and therapeutic approach are addressed.
UR - http://www.scopus.com/inward/record.url?scp=0032011733&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0032011733&partnerID=8YFLogxK
U2 - 10.1016/S1079-2104(98)90011-7
DO - 10.1016/S1079-2104(98)90011-7
M3 - Article
C2 - 9540086
AN - SCOPUS:0032011733
SN - 1079-2104
VL - 85
SP - 293
EP - 300
JO - Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics
JF - Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics
IS - 3
ER -